NCT06431100View on ClinicalTrials.gov

a Single-arm, Single-center, Open Clinical Study

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

July 19, 2023

Primary Completion Date

July 19, 2026

Study Completion Date

November 19, 2026

Conditions
Gastric CancerEsophageal CancerCervical CancerNon-Small Cell Lung Cancer NSCLCTriple Negative Breast Cancer TNBC
Interventions
BIOLOGICAL

TCR T-cells

The strengthened T cells are re-infused into the patient to achieve the killing effect

Trial Locations (1)

450052

RECRUITING

First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Beijing Geekgene Technology Co., LTD

INDUSTRY